Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: Implication for X-adrenoleukodystrophy

Journal of Neurochemistry

Volumn 71, Issue 1, 1998, Pages 78-87

  Khan, Mushfiquddin ^a   Pahan, Kalipada ^a   Singh, Avtar K ^b   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Adrenoleukodystrophy; Cytokines; Glia; Nitric oxide; Very long chain fatty acids

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ANIMAL CELL; ARTICLE; CELL MEDIATED CYTOTOXICITY; DEMYELINATION; FATTY ACID OXIDATION; GENETIC TRANSFECTION; GLIA CELL; INFLAMMATORY CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; SEQUENCE HOMOLOGY; X CHROMOSOME LINKAGE;

EID: 0031814378     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71010078.x     Document Type: Article

References (36)

1. Beier K., Volkl A., and Fahimi H. D. (1992) Suppression of peroxisomal lipid beta-oxidation enzymes of TNF-alpha. FEBS Lett. 310, 273-276.
2. Biase A. D., Avellino C., Pieroni F., Quaresima T., Grisolia A., Cappa M., and Salvati S. (1997) Effect of exogenous hexacosanoic acid on biochemical myelin composition in weaning and post-weaning rats. Neurochem. Res. 22, 327-331.
3. Cartier N., Lopez I., Moullier P., Rocchiccioli F., Rolland M. O., Jorge P., Mosser J., Mandel J. L., Bougneres P. F., Danos O., and Aubourg P. (1995) Retroviral mediated gene transfer corrects very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc. Natl Acad. Sci. USA 92, 1674-1678.
4. Contreras M., Mosser J., Mandel J. L., Aubourg P., and Singh I. (1994) The protein coded by the X-adrenoleukodystrophy gene is peroxisomal integral membrane protein. FEBS Lett. 344, 211-215.
5. De Groot C. J. A., Ruuls S. R., Theeuwes J. W. M., Dijkstra C. D., and Valk P. V. (1997) Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56, 10-20.
6. Dhaunsi G. S., Hanevold C. D., and Singh I. (1994) Impairment of peroxisomal beta-oxidation system by endotoxin treatment. Mol. Cell. Biochem. 135, 187-193.
7. Dobashi K., Pahan K., Chahal A., and Singh I. (1997) Modulation of endogenous antioxidant enzymes by nitric oxide in rat C6 glial cells. J. Neurochem. 68, 1896-1903.
8. Feinstein D. L., Galea E., Roberts S., Berquist H., Wang H., and Reis D. J. (1994) Induction of nitric oxide synthase in rat C6 glioma cells. J. Neurochem. 62, 315-321.
9. Gulati S., Ainol L., Orak J., Singh A. K., and Singh I. (1993) Alterations of peroxisomal function in ischemia-reperfusion injury of rat kidney. Biochim. Biophys. Acta 1182, 291-298.
10. Hoshi M. and Kishimoto Y. (1973) Synthesis of cerebronic acid from lignoceric acid by rat brain preparation. J. Biol. Chem. 248, 4123-4130.
11. Igarashi M., Schaumburg H. H., Powers J., Kishimoto Y., Kolodny E., and Suzuki K. (1976) Fatty acid abnormality in adrenoleukodystrophy. J. Neurochem. 26, 851-860.
12. Jaffrey S. R. and Snyder S. H. (1995) Nitric oxide: a neural messenger. Annu. Rev. Cell Biol. 11, 417-440.
13. Knazeck R. A., Rizzo W. B., Schulman J. D., and Dave J. R. (1983) Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy. J. Clin. Invest. 72, 245-250.
14. Koprowski H., Zheng Y. M., Heber-Katz E., Fraser N., Rorke L., Fu Z. F., Hanlon C., and Dietzschold B. (1993) In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic disease. Proc. Natl. Acad. Sci. USA 90, 3024-3027.
15. Lazo O., Singh A. K., and Singh I. (1991) Postnatal development and isolation of peroxisomes from brain. J. Neurochem. 56, 1343-1353.
16. Lepage G. and Roy C. C. (1986) Direct transesterification of all classes of lipids in one-step reaction. J. Lipid Res. 27, 114-120.
17. McGuinness M. C., Griffin D. E., Raymond G. V., Washington C. A., Moser H. W., and Smith K. D. (1995) Tumor necrosis factor-α and X-linked adrenoleukodystrophy. J. Neuroimmunol. 61, 161-169.
18. McGuinness M. C., Powers J. M., Bias W. B., Schmeckpeper B. J., Segal A. H., Gowda V. C., Wesselingh S. L., Berger J., Griffin D. E., and Smith K. D. (1997) Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. J. Neuroimmunol. 75, 174-182.
19. Merrill J. E., Ignarro L. J., Sherman M. P., Melinek J., and Lane T. E. (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151, 2132-2141.
20. Mitrovic B., Ignarro L. J., Motestruque S., Smoll A., and Merrill J. E. (1994) Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61, 575-585.
21. Moser H. W. (1995) Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy. J. Neuropathol. Exp. Neurol. 54, 740-745.
22. Moser H. W. (1997) Adrenoleukodystrophy: phenotype, genctics, pathogenesis and therapy. Brain 120, 1485-1508.
23. Mosser J., Douar A. M., Sarde C. O., Kioschis P., Feil R., Moser H., Poustka A. M., Mandel J. L., and Aubourg P. (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361, 726-730.
24. Nathan C. and Xie Q. (1994) Nitric oxide synthesis: roles, tolls, and controls. Cell 78, 915-918.
25. Pahan K., Namboodiri A. M. S., Sheikh F. G., Smith B. T., and Singh I. (1997a) Increasing cAMP attenuates induction of inducible nitric oxide synthase in rat primary astrocytes. J. Biol. Chem. 272, 7786-7791.
26. 6 glial cells and astrocytes. Free Radic. Biol. Med. 24, 39-48.
27. Parkinson J. F., Mitrovic B., and Merrill J. E. (1997) The role of nitric oxide in multiple sclerosis. J. Mol. Med. 75, 174-186.
28. Poulos A. (1995) Very long chain fatty acids in higher animalsa review. Lipids 30, 1-14.
29. Powers J. M. (1995) The pathology of peroxisomal disorders with pathogenetic considerations. J. Neuropathol. Exp. Neurol. 54, 710-719.
30. Powers J. M., Van L., Moser A. N., and Moser H. W. (1992) The inflammatory myelinopathy of adrenoleukodystrophy: cells, effector molecules, and pathogenetic implications. J. Neuropathol. Exp. Neurol. 51, 630-643.
31. Selmaj K. W., Raine C. S., Farooq M., Norton W. T., and Brosnan C. F. (1991) Cytokine cytotoxicity against oligodendrocytes -apoptosis induced by lymphotoxin. J. Immunol. 147, 1522-1529.
32. Singh I. (1997) Biochemistry of peroxisomes in health and disease. Mol. Cell. Biochem. 167, 1 -29.
33. Singh I., Moser A. E., Goldfischer S., and Moser H. W. (1984) Lignoceric acid is oxidized in peroxisome: implication for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc. Natl. Acad. Sci. USA 81, 4203-4207.
34. Volpe J. J. and Obert K. K. (1983) Relation of cholesterol to oligodendroglial differentiation in C-6 glial cells. J. Neurochem. 40, 530-537.
35. Whitcomb R. W., Lineham W. M., and Knazeck R. A. (1988) Effect of long chain saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J. Clin. Invest. 81, 185-188.
36. Wilson R. and Sargent J. R. (1993) Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients. J. Neurochem. 61, 290-297.